TABLE 1.

Patient demographics and procedure indications

	All patients (n = 1675)	At least 1 SSA (n = 129)	No SSA (n = 1546)	P value
Age, median (IQR), y	60.9 (54.0–68.6)	58.0 (51.7–68.2)	61.0 (54.2–68.6)	.26
Female, no. (%)	719 (42.9)	67 (51.9)	652 (42.2)	.03
Indication, no. (%)
Surveillance	694 (41.4)	47 (36.4)	647 (41.9)	.23
CRC screening	740 (44.2)	62 (48.1)	678 (43.9)	.36
Bleeding and/or anemia	178 (10.6)	15 (11.6)	163 (10.5)	.70
Change in bowel habits	102 (6.1)	6 (4.7)	96 (6.2)	.48
Abdominal pain	59 (3.5)	8 (6.2)	51 (3.3)	.09
Miscellaneous	57 (3.4)	5 (3.9)	52 (3.4)	.76

SSA, Sessile serrated adenoma; IQR, interquartile range; CRC, colorectal cancer.